Dr Reddy's Laboratories Q1 result: Net profit dips 0.90%, revenue up 13.88%

Quick Summary:

However, an 11 per cent Q-o-Q decline was observed due to reduced sales and price erosion.

The Commonwealth of Independent States (CIS) and Romania faced challenges, with a 2 per cent Y-o-Y and 11 per cent Q-o-Q revenue decline.

Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 0.90 per cent year-on-year (Y-o-Y) decline in profit after tax (PAT) during the first quarter of financial year 2024-25, concluded on June 31, reaching Rs 1,392.4 crore.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaGermanyOmanRomania

Topics: Biopharma Quarterly earnings Hyderabad-based pharma Healthcare New product launches Dr Reddy's Laboratories Global generics Active Ingredients Revenue growth NNPA Pharmaceuticals Financial performance GNPA Pharmaceutical services Dr Reddy's Laboratories PAT NII Market performance Net profit North America FY25 Q1 results

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-27 @ 18:08:16 (6 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 719 words

Reading Time: 4 minutes read

Sentences: 36 lines

Sentence Length: 20 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 21791741

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 121 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions